The Methodist Hospital is a hospital located in the Texas Medical Center in Houston, Texas. Established in 1919 as an outreach ministry of The United Methodist Church, Methodist is one of the most comprehensive teaching hospitals in the United States, with leading specialists in every field of medicine. The hospital has consistently ranked as "One of America's Best Hospitals" according to U.S. News and World Report. The hospital has earned worldwide recognition in multiple specialties including cardiovascular surgery, cancer and epilepsy treatment and organ transplatation. Primarily affiliated with Weill Cornell Medical College of Cornell University and New York-Presbyterian Hospital, the hospital directs millions of dollars into research and advances in patient care. Methodist offers the latest innovations in medical, surgical and diagnostic techniques. The Methodist Hospital system was named one of "Fortune 100 Best Companies to Work For" in 2006 and ranked ninth in the "Top 10 Companies to Work For" in 2007 and ranked eighth in 2008 according to Fortune Magazine. It now ranks seventeenth in Fortune Magazine.
Two biomarkers widely being investigated as predictors of heart and vascular disease appear to indicate risk for "silent" strokes and other causes of mild brain damage that present no symptoms, report researchers from The ...
4 / 5 (1) |
0
|
Researchers using cardiac magnetic resonance imaging (MRI) discovered that thinned non-contracting heart muscle caused by a heart attack can potentially improve in function and be reversed after cardiac bypass surgery. This ...
5 / 5 (1) |
0
|
(Medical Xpress)—The inflammation of fat tissue is part of a spiraling series of events that leads to the development of type 2 diabetes in some obese people. But researchers have not understood what triggers ...
5 / 5 (5) |
0
|
The energetic and radiant hue of emerald green has been declared the spring color of 2013. While green shirts, pants and jackets will be seen everywhere this season, so should green food on your plate.
not rated yet |
0
By loading fragile RNA into silicon nanoparticles, researchers from The Methodist Hospital and two other institutions found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 ...
not rated yet |
0
|
(Medical Xpress)—The holidays are a time to consume—food, gifts, and spirits. Here are a few alcohol-related story ideas from The Methodist Hospital. Because alcohol's effects on human physiology are complex, advice about ...
4.5 / 5 (2) |
1
(Medical Xpress)—On the morning January 13th, 2013, 25,000 people will meet at the George R Brown convention center for the biggest one day sporting event in Houston. Many of you will be running 26.2 ...
5 / 5 (2) |
1
(Medical Xpress)—The debilitating symptoms of amyotrophic lateral sclerosis, or ALS, appear to be increased by a lack of inflammation-reducing T cells, report scientists from the Methodist Neurological Institute in an upcoming ...
3 / 5 (1) |
0
|
(Medical Xpress)—The most widely used models for predicting heart failure rely on a complex combination of lifestyle, demographic, and cardiovascular risk factor information.
3 / 5 (2) |
0
(Medical Xpress)—A new tool developed by scientists at The Methodist Hospital separates tumor-causing cancer cells from more benign cells by subjecting the cells to a microscopic game of Plinko—except only the squishiest ...
4.5 / 5 (2) |
0
|
(Medical Xpress)—Research shows that managing and treating vascular disease risk factors are not only beneficial to preventing heart disease and stroke, but also common forms of dementia.
4.5 / 5 (2) |
0
(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research ...
4.5 / 5 (2) |
0
(Medical Xpress)—With a little exercise and dieting, overweight people with type 2 diabetes can still train their fat cells to produce a hormone believed to spur HDL cholesterol production, report medical researchers from ...
5 / 5 (1) |
0
|
(Medical Xpress)—Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an ...
not rated yet |
0
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...
5 / 5 (1) |
0
